Propensity-score matched pair comparison of whole brain with simultaneous in-field boost radiotherapy and stereotactic radiosurgery

Radiotherapy and Oncology

Volumn 106, Issue 2, 2013, Pages 206-209

  Rodrigues, George ^a,b   Zindler, Jaap ^c   Warner, Andrew ^a   Bauman, Glenn ^a   Senan, Suresh ^c   Lagerwaard, Frank ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain metastases; Fractionated radiotherapy; Matched pair analysis; Radiosurgery; Simultaneous in field boost

Indexed keywords

ARTICLE; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPENSITY SCORE; STEREOTACTIC RADIOSURGERY; THERAPY EFFECT; TUMOR VOLUME; WHOLE BRAIN SIMULTANEOUS IN FIELD BOOST RADIOTHERAPY;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84876066798     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.10.014     Document Type: Article

References (16)

1. M.N. Tsao, D. Rades, and A. Wirth Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline Pract Radiat Oncol 2 2012 210 225
2. S. Scoccianti, and U. Ricardi Treatment of brain metastases: review of phase III randomized controlled trials Radiother Oncol 102 2012 168 179
3. M. Kocher, R. Soffietti, and U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study J Clin Oncol 29 2011 134 141
4. H. Aoyama, H. Shirato, and M. Tago Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial JAMA 295 2006 2483 2491
5. H. Aoyama, M. Tago, and N. Kato Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone Int J Radiat Oncol Biol Phys 68 2007 1388 1395
6. E.L. Chang, J.S. Wefel, and K.R. Hess Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Lancet Oncol 10 2009 1037 1044
7. A. Baschnagel, P.L. Wolters, and K. Camphausen Neuropsychological testing and biomarkers in the management of brain metastases Radiat Oncol 17 2008 26
8. A.V. Tallet, D. Azria, F. Barlesi, J.P. Spano, A.F. Carpentier, and A. Gonçalves Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment Radiat Oncol 28 2012 77
9. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
10. P.C. Austin A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003 Stat Med 27 2008 2037 2049
11. G. Rodrigues, W. Eppinga, and F. Lagerwaard A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases Radiother Oncol 102 2012 180 186
12. F.J. Lagerwaard, E.A. van der Hoorn, W.F. Verbakel, C.J. Haasbeek, B.J. Slotman, and S. Senan Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy Int J Radiat Oncol Biol Phys 75 2009 253 259
13. G. Rodrigues, S. Yartsev, and B. Yaremko Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases Int J Radiat Oncol Biol Phys 80 2011 1128 1133
14. G. Rodrigues, G. Bauman, and D. Palma Systematic review of brain metastases prognostic indices Pract Radiat Oncol 2012 10.1016/j.prro.2012.04.001
15. B.E. Epstein, C.B. Scott, and W.T. Sause Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28 Cancer 71 1993 1362 1367
16. Rodrigues G, Warner A, Bauman G, Senan S, Lagerwaard F. Systematic review of fractionated brain metastases radiotherapy. J Radiat Oncol 2012. http://dx.doi.org/10.1007/s13566-012-0035-x.